Robert C. Doebele, MD, PhD (IMAGE)
Caption
Robert C. Doebele, MD, PhD and colleagues use virtual clinical trial to compare crizotinib with entrectinib against ROS1+ non-small cell lung cancer
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content